BACKGROUND: In 2008, the first clinic for women involved in high-risk sexual behavior was established in Kampala, offering targeted HIV prevention. This article describes rates, determinants, and trends of HIV incidence over 3 years. METHODS: A total of 1027 women at high risk were enrolled into a closed cohort. At 3-monthly visits, data were collected on sociodemographic variables and risk behavior; biological samples were tested for HIV and other reproductive tract infections/sexually transmitted infections (RTI/STIs). Hazard ratios for HIV incidence were estimated using Cox proportional hazards regression among the 646 women HIV negative at enrolment. RESULTS: HIV incidence was 3.66/100 person-years (pyr) and declined from 6.80/100 pyr in the first calendar year to 2.24/100 pyr and 2.53/100 pyr in the following years (P trend = 0.003). Sociodemographic and behavioral factors independently associated with HIV incidence were younger age, younger age at first sex, alcohol use (including frequency of use and binge drinking), number of paying clients in the past month, inconsistent condom use with clients, and not being pregnant. HIV incidence was also independently associated with Mycoplasma genitalium infection at enrolment [adjusted hazard ratio (aHR) = 2.28, 95% confidence interval (CI): 1.15 to 4.52] and with Neisseria gonorrhoeae (aHR = 5.91, 95% CI: 3.04 to 11.49) and Trichomonas vaginalis infections at the most recent visit (aHR = 2.72, 95% CI: 1.27 to 5.84). The population attributable fractions of HIV incidence for alcohol use was 63.5% (95% CI: 6.5 to 85.8) and for treatable RTI/STIs was 70.0% (95% CI: 18.8 to 87.5). CONCLUSIONS: Alcohol use and STIs remain important risk factors for HIV acquisition, which call for more intensive control measures in women at high risk. Further longitudinal studies are needed to confirm the association between M. genitalium and HIV acquisition.
BACKGROUND: In 2008, the first clinic for women involved in high-risk sexual behavior was established in Kampala, offering targeted HIV prevention. This article describes rates, determinants, and trends of HIV incidence over 3 years. METHODS: A total of 1027 women at high risk were enrolled into a closed cohort. At 3-monthly visits, data were collected on sociodemographic variables and risk behavior; biological samples were tested for HIV and other reproductive tract infections/sexually transmitted infections (RTI/STIs). Hazard ratios for HIV incidence were estimated using Cox proportional hazards regression among the 646 women HIV negative at enrolment. RESULTS: HIV incidence was 3.66/100 person-years (pyr) and declined from 6.80/100 pyr in the first calendar year to 2.24/100 pyr and 2.53/100 pyr in the following years (P trend = 0.003). Sociodemographic and behavioral factors independently associated with HIV incidence were younger age, younger age at first sex, alcohol use (including frequency of use and binge drinking), number of paying clients in the past month, inconsistent condom use with clients, and not being pregnant. HIV incidence was also independently associated with Mycoplasma genitalium infection at enrolment [adjusted hazard ratio (aHR) = 2.28, 95% confidence interval (CI): 1.15 to 4.52] and with Neisseria gonorrhoeae (aHR = 5.91, 95% CI: 3.04 to 11.49) and Trichomonas vaginalis infections at the most recent visit (aHR = 2.72, 95% CI: 1.27 to 5.84). The population attributable fractions of HIV incidence for alcohol use was 63.5% (95% CI: 6.5 to 85.8) and for treatable RTI/STIs was 70.0% (95% CI: 18.8 to 87.5). CONCLUSIONS: Alcohol use and STIs remain important risk factors for HIV acquisition, which call for more intensive control measures in women at high risk. Further longitudinal studies are needed to confirm the association between M. genitalium and HIV acquisition.
Authors: Renee Heffron; Deborah Donnell; Helen Rees; Connie Celum; Nelly Mugo; Edwin Were; Guy de Bruyn; Edith Nakku-Joloba; Kenneth Ngure; James Kiarie; Robert W Coombs; Jared M Baeten Journal: Lancet Infect Dis Date: 2011-10-03 Impact factor: 25.071
Authors: Nicolas Nagot; Abdoulaye Ouedraogo; Marie-Christine Defer; Roselyne Vallo; Philippe Mayaud; Philippe Van de Perre Journal: Sex Transm Infect Date: 2007-05-10 Impact factor: 3.519
Authors: Rupert Kaul; Joshua Kimani; Nico J Nagelkerke; Karoline Fonck; Elizabeth N Ngugi; Florence Keli; Kelly S MacDonald; Ian W Maclean; Job J Bwayo; Marleen Temmerman; Allan R Ronald; Stephen Moses Journal: JAMA Date: 2004-06-02 Impact factor: 56.272
Authors: Nicola Low; Matthew F Chersich; Kurt Schmidlin; Matthias Egger; Suzanna C Francis; Janneke H H M van de Wijgert; Richard J Hayes; Jared M Baeten; Joelle Brown; Sinead Delany-Moretlwe; Rupert Kaul; Nuala McGrath; Charles Morrison; Landon Myer; Marleen Temmerman; Ariane van der Straten; Deborah Watson-Jones; Marcel Zwahlen; Adriane Martin Hilber Journal: PLoS Med Date: 2011-02-15 Impact factor: 11.069
Authors: David Goodman-Meza; Eileen V Pitpitan; Shirley J Semple; Karla D Wagner; Claudia V Chavarin; Steffanie A Strathdee; Thomas L Patterson Journal: Am J Addict Date: 2014-07-25
Authors: Gwendolyn E Wood; Dorothy L Patton; Peter K Cummings; Stefanie L Iverson-Cabral; Patricia A Totten Journal: Infect Immun Date: 2017-01-26 Impact factor: 3.441
Authors: Kenzie Birse; Kelly B Arnold; Richard M Novak; Stuart McCorrister; Souradet Shaw; Garrett R Westmacott; Terry B Ball; Douglas A Lauffenburger; Adam Burgener Journal: J Virol Date: 2015-06-17 Impact factor: 5.103
Authors: Andrew D Redd; Deogratius Ssemwanga; Judith Vandepitte; Sarah K Wendel; Nicaise Ndembi; Justine Bukenya; Susan Nakubulwa; Heiner Grosskurth; Chris M Parry; Craig Martens; Daniel Bruno; Stephen F Porcella; Thomas C Quinn; Pontiano Kaleebu Journal: AIDS Date: 2014-09-10 Impact factor: 4.177
Authors: Marissa Salazar; Kimberly C Brouwer; Teresita Rocha-Jimenez; Sabrina C Boyce; Hugo Staines-Orozco; Jay G Silverman Journal: Subst Use Misuse Date: 2018-12-30 Impact factor: 2.164